Clinical and Microbiological Determinants of Infection After Transrectal Prostate Biopsy
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Clinical and Microbiological Determinants of Infection After Transrectal Prostate Biopsy
Authors
Keywords
-
Journal
CLINICAL INFECTIOUS DISEASES
Volume 60, Issue 7, Pages 979-987
Publisher
Oxford University Press (OUP)
Online
2014-12-17
DOI
10.1093/cid/ciu1129
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Escherichia coli ST131, an Intriguing Clonal Group
- (2014) M.-H. Nicolas-Chanoine et al. CLINICAL MICROBIOLOGY REVIEWS
- Molecular Epidemiology of Escherichia coli Sequence Type 131 and Its H30 and H30-Rx Subclones among Extended-Spectrum-β-Lactamase-Positive and -Negative E. coli Clinical Isolates from the Chicago Region, 2007 to 2010
- (2013) Ritu Banerjee et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Escherichia coli Sequence Type 131 (ST131) Subclone H30 as an Emergent Multidrug-Resistant Pathogen Among US Veterans
- (2013) Aylin Colpan et al. CLINICAL INFECTIOUS DISEASES
- Infectious Complications Following Transrectal Ultrasound-Guided Prostate Biopsy: New Challenges in the Era of Multidrug-Resistant Escherichia coli
- (2013) D. A. Williamson et al. CLINICAL INFECTIOUS DISEASES
- Systematic Review of Complications of Prostate Biopsy
- (2013) Stacy Loeb et al. EUROPEAN UROLOGY
- Modification of Antimicrobial Prophylaxis Based on Rectal Culture Results to Prevent Fluoroquinolone-Resistant Escherichia coli Infections after Prostate Biopsy
- (2013) Nuntra Suwantarat et al. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY
- Escherichia coli belonging to the worldwide emerging epidemic clonal group O25b/ST131: risk factors and clinical implications
- (2013) L. Lopez-Cerero et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Screening Rectal Culture to Identify Fluoroquinolone-resistant Organisms Before Transrectal Prostate Biopsy: Do the Culture Results Between Office Visit and Biopsy Correlate?
- (2013) Michael A. Liss et al. UROLOGY
- International Variation in Prostate Cancer Incidence and Mortality Rates
- (2012) Melissa M. Center et al. EUROPEAN UROLOGY
- Virulence of Escherichia coli Clinical Isolates in a Murine Sepsis Model in Relation to Sequence Type ST131 Status, Fluoroquinolone Resistance, and Virulence Genotype
- (2012) James R. Johnson et al. INFECTION AND IMMUNITY
- Targeted Antimicrobial Prophylaxis Using Rectal Swab Cultures in Men Undergoing Transrectal Ultrasound Guided Prostate Biopsy is Associated With Reduced Incidence of Postoperative Infectious Complications and Cost of Care
- (2012) Aisha K. Taylor et al. JOURNAL OF UROLOGY
- Virulence Potential and Genomic Mapping of the Worldwide Clone Escherichia coli ST131
- (2012) Jean-Philippe Lavigne et al. PLoS One
- Rectal Cultures Before Transrectal Ultrasound-guided Prostate Biopsy Reduce Post-prostatic Biopsy Infection Rates
- (2012) Christopher A. Duplessis et al. UROLOGY
- Complications After Prostate Biopsy: Data From SEER-Medicare
- (2011) Stacy Loeb et al. JOURNAL OF UROLOGY
- Prevalence of antimicrobial resistance in intestinal flora of patients undergoing prostatic biopsy: implications for prophylaxis and treatment of infections after biopsy
- (2010) Deepak Batura et al. BJU INTERNATIONAL
- Escherichia coli O25b-ST131: a pandemic, multiresistant, community-associated strain
- (2010) B. A. Rogers et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Increasing Hospital Admission Rates for Urological Complications After Transrectal Ultrasound Guided Prostate Biopsy
- (2010) Robert K. Nam et al. JOURNAL OF UROLOGY
- Epidemic Clonal Groups of Escherichia coli as a Cause of Antimicrobial-Resistant Urinary Tract Infections in Canada, 2002 to 2004
- (2009) J. R. Johnson et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started